Radiomics predicts risk of cachexia in advanced NSCLC patients treated with immune checkpoint inhibitors

BACKGROUND: Approximately 50% of cancer patients eventually develop a syndrome of prolonged weight loss (cachexia), which may contribute to primary resistance to immune checkpoint inhibitors (ICI). This study utilised radiomics analysis of (18)F-FDG-PET/CT images to predict risk of cachexia that can...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Br J Cancer
Hlavní autoři: Mu, Wei, Katsoulakis, Evangelia, Whelan, Christopher J., Gage, Kenneth L., Schabath, Matthew B., Gillies, Robert J.
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8292339/
https://ncbi.nlm.nih.gov/pubmed/33828255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-021-01375-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky